Screening for chronic obstructive pulmonary disease using spirometry: U.S. preventive services task force recommendation statement

Ned Calonge, Diana B. Petitti, Thomas G. DeWitt, Leon Gordis, Allen J. Dietrich, Kimberly D. Gregory, Russell Harris, George J. Isham, Michael L. LeFevre, Roseanne Leipzig, Carol Loveland-Cherry, Lucy Nelle Marion, Virginia A. Moyer, Judith K. Ockene, George F. Sawaya, Barbara P. Yawn

Research output: Contribution to journalReview article

98 Citations (Scopus)

Abstract

Description: New U.S. Preventive Services Task Force (USPSTF) recommendation about screening for chronic obstructive pulmonary disease (COPD) using spirometry. Methods: The USPSTF weighed the benefits (prevention of ≥1 exacerbation and improvement in respiratory-related health status measures) and harms (time and effort required by both patients and the health care system, false-positive screening tests, and adverse effects of subsequent unnecessary therapy) of COPD screening identified in the accompanying review of the evidence. The USPSTF did not consider the financial costs of spirometry testing or COPD therapies. Recommendation: Do not screen adults for COPD using spirometry. (Grade D recommendation).

Original languageEnglish (US)
Pages (from-to)529-534
Number of pages6
JournalAnnals of Internal Medicine
Volume148
Issue number7
DOIs
StatePublished - Apr 1 2008

Fingerprint

Spirometry
Advisory Committees
Chronic Obstructive Pulmonary Disease
Health Status
Patient Care
Delivery of Health Care
Costs and Cost Analysis
Therapeutics

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Screening for chronic obstructive pulmonary disease using spirometry : U.S. preventive services task force recommendation statement. / Calonge, Ned; Petitti, Diana B.; DeWitt, Thomas G.; Gordis, Leon; Dietrich, Allen J.; Gregory, Kimberly D.; Harris, Russell; Isham, George J.; LeFevre, Michael L.; Leipzig, Roseanne; Loveland-Cherry, Carol; Marion, Lucy Nelle; Moyer, Virginia A.; Ockene, Judith K.; Sawaya, George F.; Yawn, Barbara P.

In: Annals of Internal Medicine, Vol. 148, No. 7, 01.04.2008, p. 529-534.

Research output: Contribution to journalReview article

Calonge, N, Petitti, DB, DeWitt, TG, Gordis, L, Dietrich, AJ, Gregory, KD, Harris, R, Isham, GJ, LeFevre, ML, Leipzig, R, Loveland-Cherry, C, Marion, LN, Moyer, VA, Ockene, JK, Sawaya, GF & Yawn, BP 2008, 'Screening for chronic obstructive pulmonary disease using spirometry: U.S. preventive services task force recommendation statement', Annals of Internal Medicine, vol. 148, no. 7, pp. 529-534. https://doi.org/10.7326/0003-4819-148-7-200804010-00212
Calonge, Ned ; Petitti, Diana B. ; DeWitt, Thomas G. ; Gordis, Leon ; Dietrich, Allen J. ; Gregory, Kimberly D. ; Harris, Russell ; Isham, George J. ; LeFevre, Michael L. ; Leipzig, Roseanne ; Loveland-Cherry, Carol ; Marion, Lucy Nelle ; Moyer, Virginia A. ; Ockene, Judith K. ; Sawaya, George F. ; Yawn, Barbara P. / Screening for chronic obstructive pulmonary disease using spirometry : U.S. preventive services task force recommendation statement. In: Annals of Internal Medicine. 2008 ; Vol. 148, No. 7. pp. 529-534.
@article{b14c9c13632f4c9e9095afd0ca496096,
title = "Screening for chronic obstructive pulmonary disease using spirometry: U.S. preventive services task force recommendation statement",
abstract = "Description: New U.S. Preventive Services Task Force (USPSTF) recommendation about screening for chronic obstructive pulmonary disease (COPD) using spirometry. Methods: The USPSTF weighed the benefits (prevention of ≥1 exacerbation and improvement in respiratory-related health status measures) and harms (time and effort required by both patients and the health care system, false-positive screening tests, and adverse effects of subsequent unnecessary therapy) of COPD screening identified in the accompanying review of the evidence. The USPSTF did not consider the financial costs of spirometry testing or COPD therapies. Recommendation: Do not screen adults for COPD using spirometry. (Grade D recommendation).",
author = "Ned Calonge and Petitti, {Diana B.} and DeWitt, {Thomas G.} and Leon Gordis and Dietrich, {Allen J.} and Gregory, {Kimberly D.} and Russell Harris and Isham, {George J.} and LeFevre, {Michael L.} and Roseanne Leipzig and Carol Loveland-Cherry and Marion, {Lucy Nelle} and Moyer, {Virginia A.} and Ockene, {Judith K.} and Sawaya, {George F.} and Yawn, {Barbara P.}",
year = "2008",
month = "4",
day = "1",
doi = "10.7326/0003-4819-148-7-200804010-00212",
language = "English (US)",
volume = "148",
pages = "529--534",
journal = "Annals of Internal Medicine",
issn = "0003-4819",
publisher = "American College of Physicians",
number = "7",

}

TY - JOUR

T1 - Screening for chronic obstructive pulmonary disease using spirometry

T2 - U.S. preventive services task force recommendation statement

AU - Calonge, Ned

AU - Petitti, Diana B.

AU - DeWitt, Thomas G.

AU - Gordis, Leon

AU - Dietrich, Allen J.

AU - Gregory, Kimberly D.

AU - Harris, Russell

AU - Isham, George J.

AU - LeFevre, Michael L.

AU - Leipzig, Roseanne

AU - Loveland-Cherry, Carol

AU - Marion, Lucy Nelle

AU - Moyer, Virginia A.

AU - Ockene, Judith K.

AU - Sawaya, George F.

AU - Yawn, Barbara P.

PY - 2008/4/1

Y1 - 2008/4/1

N2 - Description: New U.S. Preventive Services Task Force (USPSTF) recommendation about screening for chronic obstructive pulmonary disease (COPD) using spirometry. Methods: The USPSTF weighed the benefits (prevention of ≥1 exacerbation and improvement in respiratory-related health status measures) and harms (time and effort required by both patients and the health care system, false-positive screening tests, and adverse effects of subsequent unnecessary therapy) of COPD screening identified in the accompanying review of the evidence. The USPSTF did not consider the financial costs of spirometry testing or COPD therapies. Recommendation: Do not screen adults for COPD using spirometry. (Grade D recommendation).

AB - Description: New U.S. Preventive Services Task Force (USPSTF) recommendation about screening for chronic obstructive pulmonary disease (COPD) using spirometry. Methods: The USPSTF weighed the benefits (prevention of ≥1 exacerbation and improvement in respiratory-related health status measures) and harms (time and effort required by both patients and the health care system, false-positive screening tests, and adverse effects of subsequent unnecessary therapy) of COPD screening identified in the accompanying review of the evidence. The USPSTF did not consider the financial costs of spirometry testing or COPD therapies. Recommendation: Do not screen adults for COPD using spirometry. (Grade D recommendation).

UR - http://www.scopus.com/inward/record.url?scp=42249091193&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=42249091193&partnerID=8YFLogxK

U2 - 10.7326/0003-4819-148-7-200804010-00212

DO - 10.7326/0003-4819-148-7-200804010-00212

M3 - Review article

C2 - 18316747

AN - SCOPUS:42249091193

VL - 148

SP - 529

EP - 534

JO - Annals of Internal Medicine

JF - Annals of Internal Medicine

SN - 0003-4819

IS - 7

ER -